After the struggle with the COVID-19 pandemic and its impacts clouding most of 2020, the rollout of vaccines against COVID-19 is the
Where do these companies stand in the COVID-19 vaccine race?
Categories
Health Care
Thermo Fisher Scientific (TMO) Earnings: 4Q20 Key Numbers
Thermo Fisher Scientific Inc. (NYSE: TMO) reported fourth-quarter 2020 earnings results today. Revenue increased 54% year-over-year to $10.55 billion. GAAP earnings jumped
Johnson & Johnson’s (JNJ) single-dose vaccine is effective but lags behind rivals
Johnson & Johnson (NYSE: JNJ) is the latest pharma company to provide results from the trial of its COVID-19 vaccine candidate. The company
Cipla Limited (CIPLA) Q3 2021 Earnings Call Transcript
Cipla Limited ( NSE : CIPLA) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Kumar Gaurav -- Vice President, Kotak Institutional Equities
Novavax (NVAX) brings its share to the COVID-19 vaccine table; stock soars
Novavax Inc.’s (NASDAQ: NVAX) shares soared 50% in morning hours on Friday after the company announced that its COVID-19 vaccine candidate displayed
Dr. Reddy’s Laboratories Ltd. (RDY) Q3 2021 Earnings Call Transcript
Dr. Reddy's Laboratories Ltd. (NYSE: RDY) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Amit Agarwal -- Head of Investor Relations Parag
Abiomed, Inc. (ABMD) Q3 2021 Earnings Call Transcript
Abiomed, Inc. (NASDAQ: ABMD) Q3 2021 earnings call dated Jan. 28, 2021 Corporate Participants: Todd A. Trapp -- Vice President and Chief Financial Officer
Abbott Laboratories (ABT) Q4 2020 Earnings Call
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions Robert
Abbott Laboratories (ABT) Q4 2020 Earnings Call Transcript
Abbott Laboratories (NYSE: ABT) Q4 2020 earnings call dated Jan. 27, 2021. Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing and Acquisitions
ABT Earnings: Key numbers from Abbott Laboratories Q4 financial results
Abbott (NYSE: ABT) today announced its fourth-quarter financial results for the period ended December 31, 2020. Net earnings for the fourth quarter
Fate Therapeutics (FATE) looks headed for a turnaround post-COVID
Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharma company, has been drawing the market's attention after reporting positive results from advanced-stage clinical
Novartis International AG (NVS) Q4 2020 Earnings Call Transcript
Novartis International AG (NYSE: NVS) Q4 2020 earnings call dated Jan. 26, 2021 Corporate Participants: Samir Shah -- Global Head, Investor Relations and Global
Johnson & Johnson (JNJ): Strength in ecommerce drives growth in Consumer Health
Shares of Johnson & Johnson (NYSE: JNJ) gained nearly 3% in morning trade on Tuesday after the company reported fourth quarter 2020
Johnson & Johnson (JNJ) beats market estimates in Q4
Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2020 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported fourth-quarter
Merck (MRK) pulls out of the COVID-19 vaccine race; will focus on investigational therapeutic candidates
Merck & Co. Inc. (NYSE: MRK) has decided to discontinue the development of its COVID-19 vaccine candidates after its clinical trials yielded
Key highlights from Kimberly-Clark (KMB) Q4 2020 earnings results
Kimberly-Clark Corporation (NYSE: KMB) reported fourth-quarter 2020 earnings results today. Net sales increased 6% to $4.8 billion year-over-year. Net income attributable to
COVID-related medical costs may weigh on UnitedHealth’s performance this year
The health insurance sector has been facing multiple challenges from the virus crisis, but market-leading healthcare firm UnitedHealth Group (NYSE: UNH) maintained
Infographic: Intuitive Surgical Q4 earnings results
Intuitive Surgical (NASDAQ: ISRG) reported fourth-quarter 2020 financial results after the regular market hours on Thursday. The robotic product's manufacturer reported fourth-quarter
Latest study shows Eli Lilly’s (LLY) antibody reduces COVID-19 by 80%
Eli Lilly and Company (NYSE: LLY) announced that the results from its latest study indicated that its monoclonal antibody bamlanivimab reduced the
Codexis (CDXS) may be moving closer to profitability, after beating slowdown
Biosciences company Codexis, Inc. (NASDAQ: CDXS) has emerged stronger from a rough patch, supported mainly by the resilience of its partners to
CEO TALKS: The story of Trxade Group (MEDS)
Probably the biggest highlight of Trxade Group Inc (NASDAQ: MEDS) is that it was set up to solve the problems faced by